Anzeige
Mehr »
Login
Dienstag, 19.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Clarity hebt ab: Massenweise sichtbares Gold (25%), Rekordvolumen und Allzeithoch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 940561 ISIN: GB0009252882 Ticker-Symbol: GS7 
Xetra
19.01.21
17:35 Uhr
15,930 Euro
+0,086
+0,54 %
1-Jahres-Chart
GLAXOSMITHKLINE PLC Chart 1 Jahr
5-Tage-Chart
GLAXOSMITHKLINE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
15,90416,01422:31
15,94015,99022:00
GlobeNewswire (Europe)
567 Leser
Artikel bewerten:
(2)

Charlesbank Capital Partners: Charlesbank Forms Bridges Consumer Healthcare, Acquires ThermaCare from GSK Consumer Healthcare

BOSTON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Funds affiliated with Charlesbank Capital Partners have announced the formation of Bridges Consumer Healthcare ("Bridges") in partnership with industry executives Robert Long and Blair Ramey. Bridges will focus on acquiring companies and assets as part of a strategy to build a market-leading consumer healthcare platform. As part of its formation, Bridges has acquired the North American rights to ThermaCare HeatW (https://protect-us.mimecast.com/s/QrDvCQWNjJfkOExwHxOQ8r?domain=thermacare.com/)raps (https://protect-us.mimecast.com/s/QrDvCQWNjJfkOExwHxOQ8r?domain=thermacare.com/) ("ThermaCare") from GSK Consumer Healthcare ("GSK"). Launched in 2001, ThermaCare is a portfolio of clinically proven heat wraps offering targeted pain management solutions for different areas of the body.

"We are excited to be partnering with Robert, Blair and the Bridges team to build a leading consumer healthcare company," said Josh Klevens, Managing Director at Charlesbank. "Robert and Blair have a proven track record of transforming over-the-counter (OTC) and personal care brands, and we see great opportunity to grow Bridges organically and through portfolio and single brand acquisitions like ThermaCare."

Mr. Long and Mr. Ramey are industry veterans who worked together at Sanofi Consumer Healthcare (formerly Chattem, Inc.) since 2006 helping to deliver industry leading revenue growth over that time. Mr. Long has more than 20 years of industry experience, including as Chief Financial Officer and Chief Executive Officer of Sanofi's North American Consumer Healthcare division, and will serve as President and CEO of Bridges. Mr. Ramey brings over 27 years of related experience, most recently as Head of Marketing and Innovation for Sanofi's US Consumer Healthcare division; he will serve as Bridges' Executive Vice President and Chief Commercial Officer. Mr. Long and Mr. Ramey bring with them other key executives with highly relevant experience and a track record of revitalizing and building numerous OTC and personal care brands.

"We are very happy to announce the partnership with Charlesbank, the formation of Bridges and the acquisition of the North American rights to ThermaCare," said Mr. Long. "ThermaCare has a leadership position within the topical pain category, a loyal consumer base and a brand name with staying power that communicates efficacy. Strategic acquisitions such as this are a priority for Bridges, and we are looking forward to additional opportunities."

"ThermaCare is a trusted brand that addresses the needs of millions of consumers looking for effective, drug-free solutions for relieving muscle pain and soreness," stated Mr. Ramey. "With a strong presence in traditional food, drug, mass-merchant and e-commerce online channels, ThermaCare is well-positioned with the growth in self-directed treatment by consumers," continued Ramey. "Brands such as ThermaCare that address unmet needs of consumers play well into our strategy of growing brands with innovation and advertising."

Bridges builds on the deep industry expertise of Mr. Long and Mr. Ramey as well as Charlesbank's experience in the OTC sector through its prior investment in Blacksmith Brands. Bridges will capitalize on compelling industry trends and intends to pursue additional acquisitions, including larger corporate carve-outs as well as the acquisition of individual brands.

Charlesbank was advised by William Blair & Company and legal counsel was provided by Weil, Gotshal & Manges LLP.

About Charlesbank Capital Partners: Based in Boston and New York, Charlesbank Capital Partners is a middle-market private investment firm managing more than $7 billion of capital. Charlesbank focuses on management-led buyouts and growth capital financings, and also engages in opportunistic credit and technology investments. The firm seeks to build companies with sustainable competitive advantage and excellent prospects for growth. For more information, please visit www.charlesbank.com (http://www.charlesbank.com).

About Bridges Consumer Healthcare: Based in Chattanooga, Tennessee, Bridges was formed in 2020 as a partnership between Robert Long, Blair Ramey and Charlesbank. Bridges' mission is to build a leading consumer healthcare company focused on OTC and personal care products and driven by consumer-led innovation and marketing.

Media Contacts:

Charlesbank Capital Partners
Maura Turner, VP, Marketing & Communications
mturner@charlesbank.com (mailto:mturner@charlesbank.com)
617-619-5457

Bridges Consumer Healthcare
Robert Long, Chief Executive Officer
robert.long@bridgeschc.com (mailto:robert.long@bridgeschc.com)
423-432-4647


GLAXOSMITHKLINE-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.